Gregory Chow

Gregory Chow

Director Financiero/CFO en SUTRO BIOPHARMA, INC. .

Fortuna: 114 203 $ al 31/07/2026

53 años
Health Technology
Finance
Consumer Services

Perfil

Gregory K.
Chow
is Chief Financial & Accounting Officer at Sutro Biopharma, Inc. since 2025.
Formerly, Mr. Chow was Chief Financial & Business Officer at NodThera Ltd. from 2024 to 2025, Chief Financial Officer at Aptose Biosciences, Inc. from 2013 to 2021, Managing Director & Director-Private Placements at Wedbush Securities, Inc. from 2012 to 2013, Director-Private Placements at RBC Capital Markets, Inc. from 2006 to 2011, Chief Financial Officer at Freenome Holdings, Inc., Chief Financial Officer at Frontier Medicines Corp., and Senior Auditor at BDO USA PC from 1995 to 1998.
Education includes an undergraduate degree from the University of California, Santa Barbara in 1994 and an MBA from The Wharton School of the University of Pennsylvania in 2005.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/06/2026 4.725 ( 0,03 % ) 114 203 $ 31/07/2026

Cargos activos de Gregory Chow

EmpresasCargoInicio
SUTRO BIOPHARMA, INC. Director Financiero/CFO 02/06/2025

Antiguos cargos conocidos de Gregory Chow.

EmpresasCargoFin
Director Financiero/CFO 01/03/2025
APTOSE BIOSCIENCES INC. Director Financiero/CFO 26/03/2021
Director Ejecutivo 01/01/2013
Corporate Officer/Principal 01/01/2011
Comptroller/Controller/Auditor 01/08/1998
Ver el detalle de la experiencia de Gregory Chow.

Formación de Gregory Chow.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology